VAPA and hepatocellular carcinoma: Meanwhile, the VAPA‐enriched LOs‐induced formation of resorption pits on bone slice, the bone slice‐released TGF‐β, and the relative growth rate of HCC cells decreased significantly in response to LOs/187‐1 or LOs/Wiskostatin treatment (Figure 8B).